Publikationen, an denen er mitarbeitet Luis Sierrasesúmaga Ariznavarreta (13)

2016

  1. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes

    Radiotherapy and Oncology, Vol. 119, Núm. 1, pp. 30-34

2015

  1. A genome-wide scan identifies variants in NFIB associated with metastasis in patients with osteosarcoma

    Cancer Discovery, Vol. 5, Núm. 9, pp. 920-931

  2. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  3. Germline TP53 Variants and Susceptibility to Osteosarcoma

    Journal of the National Cancer Institute, Vol. 107, Núm. 7

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

  2. The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity

    Journal of Bone and Mineral Research, Vol. 29, Núm. 10, pp. 2287-2296

2013

  1. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2011

  1. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

    Cancer Biomarkers, Vol. 10, Núm. 1, pp. 35-41

2009

  1. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

    Clinical Cancer Research, Vol. 15, Núm. 16, pp. 5082-5091

2008

  1. CDH11 expression is associated with survival in patients with osteosarcoma

    Cancer Genomics and Proteomics, Vol. 5, Núm. 1, pp. 37-42

2006

  1. Use of brachytherapy in children with cancer: The search for an uncomplicated cure

    Lancet Oncology, Vol. 7, Núm. 2, pp. 157-166

2004

  1. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas

    Brachytherapy, Vol. 3, Núm. 4, pp. 196-200

2003

  1. Bone HDR brachytherapy in a patient with recurrent Ewing's sarcoma of the acetabulum: Alternative to aggressive surgery

    Brachytherapy, Vol. 2, Núm. 2, pp. 114-116